Add to ORKGPatients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains. We describe a case in which a nongroupable meningococcal strain, which rarely causes disease in healthy persons, caused fatal disease in an eculizumab recipient despite meningococcal vaccination.2018C06 RR016226/RR/NCRR NIH HHS/United StatesR01 AI046464/AI/NIAID NIH HHS/United StatesR01 AI114701/AI/NIAID NIH HHS/United States30015608PMC6056112655
Invasive meningococcal infections are hyperendemic in Iceland, a relatively isolated country in the ...
Meningococcal infections may develop as episodic or endemic cases particularly among children attend...
Item does not contain fulltextPURPOSE: A new meningococcal conjugate vaccine (MCV4) was introduced i...
Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported ca...
BackgroundNon-meningococcal and nongonococcal Neisseria spp. are usually commensal and rarely cause ...
We describe a case of invasive meningococcal disease due to a vaccine-preventable and penicillin-res...
20192021-03-01T00:00:00ZCC999999/ImCDC/Intramural CDC HHS/United States31783062PMC7197327799
July 7, 2017, 11:00 ET (11:00 AM ET)CDCHAN-00404Summary: Eculizumab (Soliris\uae) recipients have a ...
Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulat...
Background.Gonorrhea is the second most commonly reported notifiable condition in the United States....
We reviewed university-based outbreaks of meningococcal disease caused by serogroup B and vaccinatio...
s u m m a r y Introduction: Invasive meningococcal disease (IMD) caused by non-serogroupable (NG) st...
Meningococcal disease is a sudden-onset, life-threatening illness caused by the bacterium Neisseria ...
Abstract Background Invasive Meningococcal Disease (IMD) is a rare and critical disease in Japan. Mo...
Although most invasive meningococcal disease (IMD) cases are sporadic without identified transmissio...
Invasive meningococcal infections are hyperendemic in Iceland, a relatively isolated country in the ...
Meningococcal infections may develop as episodic or endemic cases particularly among children attend...
Item does not contain fulltextPURPOSE: A new meningococcal conjugate vaccine (MCV4) was introduced i...
Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported ca...
BackgroundNon-meningococcal and nongonococcal Neisseria spp. are usually commensal and rarely cause ...
We describe a case of invasive meningococcal disease due to a vaccine-preventable and penicillin-res...
20192021-03-01T00:00:00ZCC999999/ImCDC/Intramural CDC HHS/United States31783062PMC7197327799
July 7, 2017, 11:00 ET (11:00 AM ET)CDCHAN-00404Summary: Eculizumab (Soliris\uae) recipients have a ...
Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulat...
Background.Gonorrhea is the second most commonly reported notifiable condition in the United States....
We reviewed university-based outbreaks of meningococcal disease caused by serogroup B and vaccinatio...
s u m m a r y Introduction: Invasive meningococcal disease (IMD) caused by non-serogroupable (NG) st...
Meningococcal disease is a sudden-onset, life-threatening illness caused by the bacterium Neisseria ...
Abstract Background Invasive Meningococcal Disease (IMD) is a rare and critical disease in Japan. Mo...
Although most invasive meningococcal disease (IMD) cases are sporadic without identified transmissio...
Invasive meningococcal infections are hyperendemic in Iceland, a relatively isolated country in the ...
Meningococcal infections may develop as episodic or endemic cases particularly among children attend...
Item does not contain fulltextPURPOSE: A new meningococcal conjugate vaccine (MCV4) was introduced i...